<DOC>
	<DOCNO>NCT00487240</DOCNO>
	<brief_summary>The purpose study examine efficacy safety insulin lispro protamine suspension ( ILPS ) compare insulin detemir basal insulin combine mealtime insulin therapy patient type 1 diabetes . A gatekeeper strategy employ sequentially test secondary objective .</brief_summary>
	<brief_title>Comparison Two Basal Insulin Therapies Patients With Type 1 Diabetes</brief_title>
	<detailed_description>Phase 3b , randomize , multicenter , multinational , open-label , two-arm , active control , parallel study determine safety , efficacy , noninferiority basal analog insulin lispro protamine suspension ( ILPS , also refer NPL [ neutral protamine Hagedorn ] ) , inject two time day , compare basal analog insulin detemir , inject two time day , measure change hemoglobin A1c ( HbA1c ) baseline ( Visit 2 ) 32 week adult patient type 1 diabetes use combination bolus insulin lispro , inject three time day .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Lispro</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<mesh_term>Protamines</mesh_term>
	<criteria>Clinical diagnosis type 1 diabetes one year Age 18 year old Body mass index ( BMI ) less equal 35 kilogram per square meter ( kg/m2 ) Have hemoglobin A1c ( HbA1c ) 1.2 2.0 time upper limit normal ( ULN ) reference range within 30 day prior Visit 1 collect analyzed local laboratory Visit 1 As determined investigator , capable willing following : perform self monitor blood glucose ( SMBG ) , complete patient diary require protocol , use insulin injection device ( ) accord instruction provide , receptive diabetes education , comply require study visit . Have take oral antihyperglycemic medication ( OAMs ) within 3 month prior Visit 1 . Have one episode severe hypoglycemia , define Abbreviations Definitions section protocol , within 6 month prior entry study Are pregnant intend become pregnant course study sexually active woman childbearing potential actively practice birth control method determine investigator medically acceptable woman breastfeed Are receive chronic ( lasting longer 14 consecutive day ) systemic glucocorticoid therapy ( exclude topical , intraarticular , intraocular , inhaled preparation ) receive therapy within 4 week immediately precede Visit 1 . Have receive treatment within last 30 day drug receive regulatory approval indication time study entry .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>diabetes</keyword>
	<keyword>type 1</keyword>
</DOC>